Zoetis (ZTS) EBIT (2012 - 2026)

Zoetis (ZTS) has 15 years of EBIT data on file, last reported at $833.0 million in Q1 2026.

• On a quarterly basis, EBIT fell 1.3% year-over-year to $833.0 million in Q1 2026; TTM through Mar 2026 was $3.6 billion, a 4.01% increase from a year earlier, with the FY2025 full-year figure at $3.7 billion, up 5.63% from the prior year.
• EBIT for Q1 2026 stood at $833.0 million, down from $841.0 million in the prior quarter.
• Over the last five years, EBIT for ZTS reached as high as $992.0 million in Q2 2025 and fell as low as $728.0 million in Q4 2022.
• Historically, EBIT has averaged $834.8 million across 5 years, with a median of $833.0 million in 2026.
• Across the five-year window, EBIT soared 62.67% in 2022 and declined 10.14% in 2023, its largest moves.
• Year by year, EBIT stood at $728.0 million in 2022, then gained by 1.37% to $738.0 million in 2023, then advanced by 7.99% to $797.0 million in 2024, then gained by 5.52% to $841.0 million in 2025, then retreated by 0.95% to $833.0 million in 2026.
• Per Business Quant data, the three most recent EBIT figures were $833.0 million in Q1 2026, $841.0 million in Q4 2025, and $964.0 million in Q3 2025.